Abstract
The in vivo assessment of epigenetic changes during mouse pancreatic beta-cell differentiation reveals surprising differences to directed, in vitro differentiation of human embryonic stem cells. New findings reported in this issue of The EMBO Journal further identify Ezh2 as a critical determinant of endocrine progenitor number and could instruct improved protocols for stem cell-based therapies.
Original language | English |
---|---|
Pages (from-to) | 2135-2136 |
Number of pages | 2 |
Journal | EMBO Journal |
Volume | 33 |
Issue number | 19 |
DOIs | |
State | Published - 2014 |
Externally published | Yes |